During the past decade, Clinical Ageing Research Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Ageing Research Unit" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Knopp Biosciences" with 2 trials sponsored, "Gateshead Health NHS Foundation Trust" with 1 trials sponsored, "Newcastle-upon-Tyne Hospitals NHS Trust" with 1 trials sponsored and "Newron Pharmaceuticals SPA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Ageing Research Unit" #1 collaborator was "Biogen" with 1 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator, "Newcastle University" with 1 trials as a collaborator, "Newcastle-upon-Tyne Hospitals NHS Trust" with 1 trials as a collaborator and "i3 Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Ageing Research Unit" are "Amyotrophic Lateral Sclerosis" (2 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials), "Depression" (1 trials) and "Idiopathic Parkinson's Disease" (1 trials). Many other conditions were trialed in "Clinical Ageing Research Unit" in a lesser frequency.

Most popular intervention types in "Clinical Ageing Research Unit" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Dexpramipexole" (2 trials), "Gantenerumab" (2 trials), "Amlodipine" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Ageing Research Unit" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Ageing Research Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinical Ageing Research Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Ageing Research Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Clinical Ageing Research Unit has several departments that took part in Clinical trials: "NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham" - 2 trials, "Royal Liverpool University Hospital Clinical Research Unit" - 2 trials, "Yorkshire Regional Clinical Trials & Research Unit" - 2 trials, "Newcastle University Clinical Ageing Research" - 2 trials